Intangible Asset

12 Months Ended

Dec. 31, 2017

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Asset

(3)    Intangible Asset

Intangible asset consists of the historical acquisition cost of certain technology rights for Vascepa and has an estimated weighted-average remaining useful life of 12.6 years. The carrying value as of December 31, 2017 and 2016 is as follows:

In thousands	December 31, 2017			December 31, 2016
Technology rights	$	11,624		$	11,624
Accumulated amortization		(3,498	)		(2,852	)
Intangible asset, net	$	8,126		$	8,772

Amortization expense for each of the years ended December 31, 2017 and 2016 was $0.6 million and is included in research and development expense. Estimated future amortization expense, based upon the Company’s intangible asset, as of December 31, 2017 is as follows:

In thousands
Year Ending December 31,	Amount
2018	$	646
2019		646
2020		646
2021		646
2022		646
Thereafter		4,896
Total	$	8,126